Amyloid of b 2 -microglobulin (b 2 m) origin can be diagnosed using 131 I-radiolabelled-b 2 m scintigraphy in patients with uremia and hemodialysis treatment. As the tracer b 2 m is isolated from another patient, it carries the common risks, including viral infections such as Hepatitis B, C and HIV, which are associated with human plasma products.
Amyloidosis of b 2 -macroglobulin (b 2 m) origin is a serious disease in patients with long-standing uremia and hemodialysis treatment. It is seen to occur with increasing prevalence with the duration of dialysis, with age of the patient and with the kind of dialyzer used [1±3] . As this class of amyloidosis causes severe osteo-articular symptoms with carpal tunnel syndrome and bone erosions which lead to pathologic bone fractures, early diagnosis is needed in order to achieve a timely therapeutic intervention.
As early bioptic diagnosis has not yet been established, minimal invasive scintigraphic diagnosis has been reported using 131 I-labelled b 2 m [4] which was confirmed by others [5±7]. However, the tracer b 2 m in all studies was isolated from urine or uremic ultrafiltrate of other patients. Although these selected donor patients had been carefully scrutinized for any possible transmissible disease, there still remains a risk, including viral infections such as Hepatitis B, C and HIV, inherent in all human plasma products.
As such a tracer may only be applicable in a limited and strictly controlled setting, it cannot be commonly applied and its commercial distribution is not feasible due to the remaining risks. The same applies to the human amyloid-P component scintigraphy which has been used to diagnose various amyloidoses including b 2 m-amyloidosis [8±10] .
To avoid the mentioned risks and increase security we have expressed the human precusor b 2 m as a recombinant protein.
Here, we present its production, isolation and characterization. Finally, we illustrate the applicability of this protein as a tracer for scintigraphic identification and the localization of anatomical sites containing amyloid of the b 2 m-class.
M A T E R I A L S A N D M E T H O D S
Construction of the expression plasmid pASK40DLhb 2 m(His) 5 Human b 2 -microglobulin (b 2 m) was produced in Escherichia coli as a recombinant polypeptide with five histidine residues attached to the carboxyterminus.
RNA of the human lymphoblastoid B cell line LG2 was isolated and transcribed into cDNA as previously described [11] . One mL cDNA was amplified by PCR (5 cycles 1 minute annealing at 46 8C, 1 minute elongation at 72 8C and 25 cycles with an annealing temperature of 66 8C) with a 5
H -oligonucleotide (5 H -GCGCTCGGTACCTATCCAGCGTACTCC-3 H ) containing a KpnI recognition sequence (underlined) with ATC encoding the first amino-acid, isoleucine, of the mature b 2 m polypeptide. The 3
H ) has a HindIII recognition sequence (underlined) and adds five histidine q FEBS 2000 residues to the C-terminal methionine and two consecutive translational termination codons. The amplified fragments were digested with KpnI and HindIII, purified by agarose gel electrophoresis and ligated into the vector pASK40 cut with KpnI and HindIII. Restriction enzymes, T4 ligase, Taq polymerase, and reverse transcriptase were purchased from Boehringer Mannheim, Germany. The recombinant subclones were sequenced to confirm the inserted b 2 m sequence. The N-terminal sequence of mature b 2 m was fused to the ompA signal peptide by deleting the sequence between the ompA signal peptide sequence and the ATC of the b 2 m sequence via in vitro mutagenesis [12] . Site-directed mutagenesis was performed with a single-stranded template, and the oligonucleotide b 2 m±deletion: 5
H -GAGTACGCTGGATGGCCTG-GCGTA-3 H and Klenow polymerase (Boehringer Mannheim) following standard protocols. In vitro generated doublestranded plasmid was transformed into JM83 bacteria [12] . Colonies were transferred to Hybond N + filters (Amersham Buchler, Braunschweig, Germany) and screened by hybridization with the 32 P-labelled b 2 m±del oligonucleotide following the protocol of Cate et al. [13] .
Expression of rhb 2 m
The protein rhb 2 mH 5 was expressed basically following [12] . In brief, a culture grown agitated in LB-medium (10 g tryptone, 5 g yeast extract, both from Difco Lab., Augsburg, Germany; 10 g NaCl in 1 L of demineralized H 2 O) supplemented with 100 mg´L 21 ampicillin (Sigma, Deisenhofen) at room temperature overnight was added to a 200-mL and later a 2-L culture, and incubated in the same manner. At a bacterial density of D 560 = 0.6 isopropyl thio-b-d-galactoside (IPTG, Sigma) was added to a final concentration of 1 mm. After 9 h incubation at room temperature the cells (D 560 = 1.5) were collected by centrifugation at 8000 g (Sorvall ultracentrifuge, rotor SS34) for 30 min at 4 8C. In order to optimize the procedure, the temperature and time of incubation, without and with IPTG, have been varied. As shown in Fig. 1 , cells were grown at 37 8C or 22 8C (room temperature) for 6, 12 or 24 h before they were induced by IPTG for another 3, 6 or 12 h. Cells were harvested and the concentration of rhb 2 H 5 determined by radial immunodiffusion [14] .
Isolation using immobilized metal ion affinity chromatography (IMAC)
A chelating Sepharose Fast Flow column (15 mL, Pharmacia Biotech GmbH, Freiburg, Germany) was regenerated using 50 mm EDTA in 1 m NaCl at pH 8.0 and subsequently washed with bidistilled water. The column was then loaded with 20 mL of ZnCl 2 (1 mg´mL
21
) and washed again with water. After equilibration with 50 mm Tris/HCl and 1 m NaCl at pH 8.0 the supernatant of the bacterial lysate was applied and run in the same buffer. The cells from a 10-L culture were resuspended in 50 mL of 50 mm Tris/HCl, 1 m NaCl, pH 8.0, passed twice through a French press (Aminco, SCM Instruments Inc, Urbana, IL, USA) at 920 bar, and centrifuged at 35 000 g for 30 min at 10 8C (Sorvall). The supernatant was cleared from the remaining DNA and RNA by benzonase (1 IU´mL 21 in 1 mm MnCl 2 ; Merck, Darmstadt, Germany) before chromatography. The column was washed with Tris/HCl buffer, preeluted with 10 mm and subsequently with 15 mm imidazole (Sigma) before the imidazole gradient of 15±200 mm was started for eluting the rhb 2 mH 5 ( Fig. 2) . The rhb 2 mH 5 was identified, quantitatively monitored and compared with native b 2 m isolated from urine (purchased from Sanderson Co., Sussex, UK) and from an uremic ultrafiltrate [15] using twodimensional double immunodiffusion [16] and radial immunodiffusion [14] . Fractions containing rhb 2 mH 5 were collected and concentrated via Centricon-3 (Amicon GmbH, Witten, Germany) to approximately 3 mg´mL 21 and applied to a Superose 12 column (Pharmacia GmbH) run in 0.75 m NH 4 HCO 3 , pH 8.0. The effluent was fractionated and quantitatively monitored [14] . Fractions containing rhb 2 mH 5 were collected, concentrated in the same way and stored frozen. Part of the protein preparation was dialyzed against water and lyophilized for analysis.
Quality control
Uniformity of the isolated rhb 2 mH 5 was probed using polyacrylamide gel electrophoresis [17] , Western blotting [18] using a rabbit anti-b 2 m serum (Dakopatts, Glostrup, Denmark), two-dimensional electrophoresis in polyacrylamide (charge± size, using isoelectric focusing and sizing in SDS [19] ) as well as electrospray mass spectrometry on an API III triple quadrupole mass spectrometer (Sciex, Toronto, Canada). For further details see Fig. 3 . N-terminal amino-acid sequence analysis was performed using a model 477A protein sequencer (Applied Biosystems, Weiterstadt, Germany) according to standard protocols provided by the company.
Lyophilized rhb 2 mH 5 was dissolved at different concentrations in a variety of buffers. Crystallization was attempted with various precipitants [20] in a hanging drop at 4 8C for several months per set.
Patient
A 51-year-old male patient, with chronic glomerulonephritis and a hypoplastic left kidney, finally resulting in anuria, underwent home-dialysis from age 23 for 13 years followed by center dialysis for another 11 years. A first renal transplantation at age 47 was not successful. A second Whole body scintigraphy with indium-111-labelled rhb 2 mH 5 At age 50, the local Ethics Commission at the Medical Faculty of the University of Hannover, Germany, approved the current study, and the patient consented to undergo a second scintigraphy using the recently improved method employing rhb 2 mH 5 described here. The transformed E. coli clone and the protocol of production and isolation was handed over to Boehringer Co (today Roche-Pharma) Penzberg, Germany which produced this protein under GMP (general medical practice) conditions that allow the diagnostic application to humans as described previously [21] . The rhb 2 mH 5 was radiolabelled with 111 In via the covalently bound chelator diethylentriamin-pentacetic acid (DTPA) (Aldrich) [22] . At day zero, 70 MBq (< 70 mg) of 111 In-DTPA-rhb 2 mH 5 was intravenously injected. A low-flux dialysis at day one and a high-flux dialysis at day three followed in order to remove circulating tracer for minimal background tracing. Whole body scintigraphy and additional images of selected joint regions were carried out on day three. Regional images are shown in Fig. 4 .
R E S U L T S

Identification of the correct DNA sequence
Plasmids of positive clones were analyzed by restriction enzyme digestion and DNA sequencing for the presence of the correct b 2 m sequence fused to the ompA signal peptide. One clone, showing the identical sequence to the wild type b 2 m, DLhub 2 m(His) 5 was used to produce recombinant human b 2 m in E. coli.
Improving the expression of rhb 2 mH 5
Initial experiments with bacterial cells induced with IPTG at 37 8C resulted only in a marginal expression of rhb 2 mH 5 or no expression at all, while cell growth and production of rhb 2 mH 5 greatly improved at room temperature, i.e. 22 8C (Fig. 1) . Therefore, the optimal expression was examined under different conditions as detailed in Fig. 1 . The highest expression of almost 3 mg´L 21 of bacterial medium was measured when cells were grown for 6 h at 37 8C and induced with IPTG for 12 h at 22 8C.
Expression and isolation
Using optimal expression conditions rhb 2 mH 5 was produced in several different volumes including a fermenter of 150 L. One example isolating rhb 2 mH 5 using IMAC from approximately 30 g of bacterial cells (wet weight) is shown in Fig. 2 . The preeluting steps using 10 mm and subsequently 15 mm (or only 15 mm) of imidazole primarily removed proteins which immediately preceded the peak representing rhb 2 mH 5 , thus yielding a protein of at least 90% purity with a purification factor of approximately 1000 using IMAC. Quantitative determination of rhb 2 mH 5 revealed that the effluent of the imidazole gradient contained the majority of the rhb 2 mH 5 as the unbound proteins of the effluents of both prewash eluates and the regeneration step were found to be free or almost free of rhb 2 mH 5 . Only the 15 mm preeluting fraction contained a trace of rhb 2 mH 5 (Fig. 3, lane 3 in B, small arrow) . A further isolation step included size-exclusion chromatography (Fig. 5) . The major protein of 11.8 kDa was immunochemically shown to represent rhb 2 mH 5 . The main protein was collected as indicated (cross-hatched fractions) and analyzed as shown below. From 30 g of packed cells approximately 8 mg of pure protein was isolated.
Characterization
The isolated rhb 2 mH 5 was examined using polyacrylamide gel electrophoresis together with other effluents and eluates.
As shown in Fig. 3A , lane 4 and 5 the purified rhb 2 mH 5 represents a single band at 11.8 kDa. Western blot analysis in Fig. 3B identified this protein as rhb 2 mH 5 . Aside from this 11.8-kDa band, a dimer (23 kDa) appeared after sizeexclusion chromatography and lyophilization (Fig. 3B, lane 6) . This dimer was detected neither in the original cell lysate (Fig. 3A, lane 1) nor after IMAC (Figs 3 and 5) . Overloading of the polyacrylamide gel allowed to estimate the purity of the rhb 2 mH5 (not shown). The isolated protein had at least 98% purity.
In two-dimensional polyacrylamide gel electrophoresis (isoelectric focussing and sizing), only one single spot was visible, a feature which indicates uniformity (not documented). The isoelectric point was found to be at 6.8. The higher value as compared to the native protein of 5.9 is most likely due to the pentahistidine tail added for easy purification.
The N-terminal amino-acid sequence was identical to the one of the native protein in the first 27 amino-acid residues determined and also identical up to position 39, except for 3 residues that could not be determined (33, 35 and 38, marked with * below) and two uncertainties in position 28 (serine) and 36 (glutamic acid) (as indicated with s and e, respectively). The missing amino acid in position 35 is consistent with the presence of cysteine. The sequence of rhb 2 mH 5 obtained is: IQRTP KIQVY SRHPA ENGKS NFLN* YVsGF HP*DI eV*L.
Electrospray-mass spectrometry (Fig. 6 ) resulted in a single peak of 12 415.8 Da which is two protons less than the calculated value of 12 417.9 Da of the reduced form, in good agreement with the assumption of an intact disulfide bridge. Thus, the rhb 2 mH 5 had exactly the predicted mass value.
Crystallization experiments resulted in crystals under one condition (0.1 m Tris/HCl, 0.2 m ammonium sulfate, 2.0 m K/Na phosphate, pH 6.5, at 4 8C.). These crystals (approx. 0.2 mm length, Fig. 5, inset) , however, did not allow the establishment of the X-ray structure. We are in the process of improving the crystals by varying the conditions including hysteresis experiments which had been performed with the expectation to possibly improve the packing of rhb 2 mH 5 in these crystals [23, 24] .
Whole body scintigraphy using 111 In-DPTA-rhb 2 mH 5
As shown in Fig. 4 , scintigraphic labelling occurred in anatomical regions known to contain amyloid [2±7]. In q FEBS 2000 Fig. 4a , a palmar scan image of both hands and forearms revealed pronounced tracer accumulation in both elbow regions, both wrists and metacarpo-phalangeal joints on the left. Figure 4b shows a ventral image of the shoulders with bilateral positive tracer uptake, nonspecific tracer uptake by the liver and, to a lesser extent, in the spleen is also visible. This uptake by the reticulo-endothelial system is most likely unspecific for amyloid as it occurs with other 111
In-labelled proteins and with free indium as well. The traced regions are identical to those identified with the first imaging using radioiodine-b 2 m (see above) and conform with the characteristic distribution of Ab 2 m amyloid.
D I S C U S S I O N
In order to reduce the potential risks of plasma proteins for patients and to standardize the tracer for better resolution we produced and characterized rhb 2 mH 5 . Expressed in transformed E. coli with a vector introducing a correct removal of the ompA signal peptide and adding the carboxyterminal pentahistidine tail, this protein could be isolated to nearly absolute purity by a two step procedure. We found no indication of any interference of the pentahistidine tail that could have altered properties of this rhb 2 mH 5 except for the pI. The mild purification procedure allowed the isolation of rhb 2 mH 5 in an apparently functional state in agreement with findings on functional immunoglobulin domains which were also produced with a (His) 5 -tag [24] .
The rhb 2 mH 5 was homogeneous according to charge and mass. There was only one single N-terminal amino-acid sequence without any hint of another peptide proving identity with the natural protein without degradation during the isolation procedure. The correct sequence was also supported by results obtained by mass spectrometry which identified the expected molecular mass. The lack of two protons on the rhb 2 mH 5 mass as compared to the calculated mass is consistent with the intact disulfide bridge (as in the native protein). Our rhb 2 mH 5 was stable in physiological buffers, it could be frozen and lyophilized. It could be crystallized, although its internal packing was not sufficiently ordered to establish its three-dimensional structure. This rhb 2 mH 5 reacted immunochemically [14, 16] identical to human native b 2 m isolated from ultrafiltrate or urine.
Most importantly, this rhb 2 mH 5 , after 111 In-labeling, revealed an identical scintigraphic distribution and fixation pattern in the same patient diagnosed with human 131 I-labeled isolated from ultrafiltrate years before. This also includes the uptake in the spleen and liver which is also observed in other In-labeled proteins. Thus, this new tracer is as specific for organs containing Ab 2 m-amyloid as natural b 2 m as no tracer was fixed in organs lacking amyloid and no fixation above background has been noted in patients without amyloidosis [21] .
The recombinant tracer will not only increase safety for the patient by excluding human plasma proteins with all the inherent risks (hepatitis B and C, HIV and others), but will also reduce considerably the radioactive load for each examination (by 50±70%) by improving the labelling technique using the radioactive tracer 111 In [21, 22] . Another important advantage is the higher resolution of the whole body scintigraphy which improves the diagnostic value of this reagent. This new tracer has been applied to a series of patients with excellent results [21] . Thus, 111 In-rhb 2 mH 5 scintigraphy has the potential to serve as a valuable tool world-wide for the early, specific and non-(or mininal-)invasive diagnosis of Ab 2 m amyloidosis in patients with uremia and end stage renal diseases.
Finally, this rhb 2 mH 5 can also be used as a model protein for clarifying important questions concerning the pathogenesis of b 2 m amyloidosis in vitro. It seems to be well suited as it excludes the presence of any other human plasma protein that could unintenionally interfere with experiments investigating the amyloidogenesis in vitro.
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